Alliance Witan PLC - Transaction In Own Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail| Alliance Witan PLC |
| LEI: 213800SZZD4E2IOZ9W55 |
| TRANSACTION IN OWN SHARES |
| Alliance Witan PLC (“the Company”) announces that today the Company purchased 100,000 ordinary shares of 2.5p each at a price of 1,216.0p per share, to be held in Treasury. |
| Following the transaction, the Company’s issued share capital comprises 405,193,982 ordinary shares of which 4,202,000 ordinary shares are held in Treasury. Therefore, the total voting rights in the Company is 400,991,982 ordinary shares. |
| For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should exclude any shares held in Treasury and should use the figure 400,991,982 when determining if they are required to notify their interest in, or a change to their interest in the Company. |
| Enquiries: |
| Juniper Partners Limited |
| Company Secretary |
| Telephone: 0131 378 0500 |
| 25 October 2024 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arrvel Introduces Industrial Barcode Scanner and Handheld Terminal Lineup for Global Enterprises
- VIGGO Cleaning Robots Log Over 20,000 Operating Hours at Beijing's CapitaMall Taiyanggong
- Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
